Evidence map›Paper›PMID 39629681›Full record

SynthesisEmerging microbes & infections2025

Antimicrobial resistance in hypermucoviscous and non-hypermucoviscous

Hiroki Namikawa, Ken-Ichi Oinuma, Yukihiro Kaneko, Hiroshi Kakeya, Taichi Shuto

Abstract readSystematic ReviewMeta-Analysis
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Emerging microbes & infections, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. [Clinical and molecular characteristics of neonatalZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2026
    Article
  2. Complete genome sequences of twoMicrobiology resource announcements · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hiroki NamikawaDepartment of Medical Education and General Practice, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
Ken-Ichi OinumaDepartment of Bacteriology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
Yukihiro KanekoDepartment of Bacteriology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
Hiroshi KakeyaResearch Center for Infectious Disease Sciences, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
Taichi ShutoDepartment of Medical Education and General Practice, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance has recently increased due to emerging carbapenem-resistant

Indexed as

Anti-Bacterial Agentsbeta-LactamasesKlebsiella InfectionsKlebsiella pneumoniaeCarbapenemsDrug Resistance, BacterialHumansMicrobial Sensitivity TestsAnti-Bacterial Agentsbeta-LactamasesCarbapenemsantimicrobial resistancecarbapenem-resistantextended-spectrum beta-lactamasehypermucoviscousKlebsiella pneumoniae

Identifiers

PMID39629681
PMCPMC11650459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.